Tyche Industries
- Market cap
- ₹ 107 Cr.
- P/E
- 24x
- P/B
- 0.77x
- 52-week range
- 99 – 148
- ROE
- 5%
- ROCE
- 6.8%
- Dividend yield
- 3.3%
- Debt / equity
- 0
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
About
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Tyche Industries against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)24 against a typical 34.3: cheaper than most peers (1st = cheapest).78th of 220
- Sales growth−28.3% against a typical +15.6% from a year earlier.179th of 197
- Profit growth−101.6% against a typical +18.9% from a year earlier.150th of 160
- Share price, 3 months−16.5% against a typical −0.5%.170th of 200
- Size₹ 106.7 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).146th of 199
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16 | 22 | 14 | 16 | 21 | 18 | 12 | 13 | 14 | 11 | 16 | 9 |
| Expenses | 13 | 17 | 12 | 13 | 16 | 13 | 13 | 11 | 14 | 9 | 17 | 11 |
| Operating Profit | 3 | 5 | 2 | 3 | 5 | 5 | −0 | 2 | −0 | 1 | −1 | −2 |
| OPM % | 19.5% | 21.7% | 13.2% | 16.9% | 23% | 27.2% | −1.5% | 15.3% | −0.9% | 10.3% | −4.1% | −18.6% |
| Other Income | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | 4 | 6 | 3 | 4 | 5 | 6 | 1 | 3 | 2 | 2 | 2 | −0 |
| Tax % | 25.3% | 26.8% | 28.7% | 24.9% | 25.5% | 25.8% | 28.6% | 25.5% | 25.9% | 26% | 31.8% | −20% |
| Net Profit | 3 | 4 | 2 | 3 | 4 | 5 | 1 | 2 | 2 | 2 | 1 | −0 |
| EPS in Rs | 3.06 | 4.19 | 2.05 | 2.66 | 3.89 | 4.62 | 0.92 | 2.37 | 1.48 | 1.78 | 1.12 | −0.04 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 0%
- 5 Years
- −7%
- 3 Years
- −11%
- TTM
- −21%
- 10 Years
- 11%
- 5 Years
- −20%
- 3 Years
- −21%
- TTM
- −65%
- 10 Years
- 5%
- 5 Years
- −10%
- 3 Years
- −15%
- TTM
- —
- 10 Years
- 12%
- 5 Years
- 9%
- 3 Years
- 8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Tyche Industries | ₹ 102.00 | ₹ 107 Cr. | 24x | 0.8x | 5% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 54.6x | 11.3x | — | 13% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 105.8x | 29.7x | — | 18.1% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 67.7x | 15.4x | — | 17.4% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 40.3x | 5.5x | — | 12.7% |
| Berger Paints India | ₹ 465.60 | ₹ 54,289 Cr. | 49.2x | 8.2x | — | 9.9% |
Management
- Gokaraju Sandeep Kumar
- Chairman of the Board, Managing Director
- Y. Srinivasa Rao
- Chief Financial Officer
- Pradosh Ranjan Jena
- Compliance Officer, Company Secretary
- G. Ganesh Kumar
- Executive Director
- Satya Srinivas Uppalapati
- Additional Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.